Omega Fund Management, LLC
Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BridgeBio Oncology Therapeutics Inc. | 0 | 3,289,661 | +3,289,661 | 0 | 38,094,274 | 17.13% | +38,094,274 |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | 20,481,199 | 34,811,424 | 15.66% | +14,330,225 |
| Kestra Med Technologies Ltd | 1,645,893 | 1,645,893 | 0 | 27,288,906 | 39,106,418 | 17.59% | +11,817,512 |
| Nuvation Bio(NUVB) | 11,042,728 | 8,831,089 | -2,211,639 | 21,533,320 | 32,675,029 | 14.69% | +11,141,709 |
| Beta Bionics Inc. | 1,988,287 | 1,920,125 | -68,162 | 28,949,459 | 38,152,884 | 17.16% | +9,203,425 |
| ImageneBio, Inc. | 0 | 455,361 | +455,361 | 0 | 3,711,192 | 1.67% | +3,711,192 |
| Upstream Bio Inc. | 2,036,293 | 1,356,293 | -680,000 | 22,358,497 | 25,511,871 | 11.47% | +3,153,374 |
| enGene Holdings Inc. | 526,357 | 526,357 | 0 | 1,915,940 | 3,595,018 | 1.62% | +1,679,078 |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | 2,303,438 | 2,995,313 | 1.35% | +691,875 |
| Alumis Inc. | 653,223 | 653,223 | 0 | 1,959,669 | 2,606,360 | 1.17% | +646,691 |
| enGene Holdings Inc. | 321,502 | 89,702 | -231,800 | 272,955 | 63,438 | 0.03% | -209,517 |
| Immunic Inc. | 1,788,160 | 0 | -1,788,160 | 1,248,136 | 0 | — | -1,248,136 |
| Ikena Oncology | 2,249,123 | 0 | -2,249,123 | 3,013,825 | 0 | — | -3,013,825 |
| Lexeo Therapeutics | 1,184,636 | 0 | -1,184,636 | 4,762,237 | 0 | — | -4,762,237 |
| Replimune Group(REPL) | 1,975,203 | 248,672 | -1,726,531 | 18,349,636 | 1,041,936 | 0.47% | -17,307,700 |